11:39 AM EST - MIS Neurosciences : Announced that it has initiated a program to identify novel therapeutic targets on neurotoxic strains of the protein TDP43, implicated in the development of Amyotrophic Lateral Sclerosis and frontotemporal dementia. MIS Neurosciences
shares T.PMN are trading up $0.01 at $0.16.
